Tivoxavir marboxil (TXM), administered as a single dose in non-human primates, significantly reduced lung viremia and prevented weight loss, two ...

Traws Pharma (TRAW) announced topline results from a study evaluating the use of tivoxavir marboxil as a treatment for non-human primates ...

New Roles in Infectious Process for Molecule That Inhibits Flu Nov. 14, 2024 — Researchers have identified new roles for a protein long known to protect against severe flu infection -- among ...

Potent Antiviral Activity in Preclinical Challenge Model: Results from a rodent challenge model showed that 100% of mice ...

New Roles in Infectious Process for Molecule That Inhibits Flu Nov. 14, 2024 — Researchers have identified new roles for a protein long known to protect against severe flu infection -- among ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

Tivoxavir marboxil (TXM) is an investigational oral, small molecule CAP-dependent endonuclease inhibitor designed to be administered as a single-dose for the treatment of bird flu and seasonal ...

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate ...

Poster underscores Tivoxavir Marboxil's potential for the treatment of bird flu, supported by 100% survival in a rodent challenge model, potent suppression of resistant viruses and Phase 1 dataFull da ...

Explore how everyday foods like leafy greens, berries, and spices can support better breathing and improve lung health.

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of novel peptide conjugate therapeutics for treating resp ...

Scientists in the US who do research on mRNA technology worry their funding may be cut under President Trump. mRNA technology is the basis for COVID- and other vaccines and could play a role in cancer ...